Raphael Pharmaceutical Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- Raphael Pharmaceutical Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-12-31 was $31.00K.
- Raphael Pharmaceutical Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2025-09-30 was $2.00K.
- Raphael Pharmaceutical Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2025 was $6.00K, a 98.52% decline from fiscal 2024.
- Raphael Pharmaceutical Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2024 was $406.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $33.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $33.00K derived: sum of 2 quarters · filed 2026-03-31 | $6.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$25.00K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | -$27.00K 10-Q · filed 2026-08-14 | |||
| 2024-12-31 | $406.00K 10-K · filed 2026-03-31 | |||
| 2024-06-30 | $346.00K 10-Q · filed 2025-08-13 |